However, greater levels of social comparison at baseline were associated with a deteriorating quality of life over the 10-month follow-up period.
Low levels of PM with father at baseline were associated with high levels of bulimic and depressive symptoms across assessment times, whereas low PM with mother was only associated with high levels of depression.
Higher mean heart rate and an elevated percentage of heart rate above baseline were associated with physical health symptoms.
High lactate levels at baseline were associated with higher in-ICU and in-hospital mortality.
Lower scores at baseline were associated with larger differences in postintervention scores between the simulator and control groups (technical performance, P=0.0006; global performance, P<0.0001).
In the present study symptoms of anxiety and depression at baseline were associated with recurrent headache at follow-up.
Higher scores of attention problems at baseline were associated with non-classifiable headache at follow-up (OR: 2.0, 95% CI: 1.3-3.4, p = 0.017).
For headache frequency, symptoms of anxiety and depression and conduct difficulties at baseline were associated with more frequent headache at follow-up.
In the multivariable model for hospitalization, older age, percentage of predicted FEV(1), unscheduled clinic/emergency department visits for COPD in the prior year, any cardiovascular comorbidity, and prednisone use at baseline were associated with greater risk.
Among adolescents without recurrent headache at baseline, symptoms of anxiety and depression were associated with new onset migraine four years later and attention difficulties at baseline were associated with new onset non-classifiable headache.
The ODS at baseline were associated with (1) greater macular drusen volume at baseline (P < 0.001), (2) development of preatrophic changes at year 2 (P = 0.001-0.01), and (3) development of macular GA (P = 0.005) and preatrophic changes at year 3 (P = 0.002-0.008), but not development of CNV.
